Form 8-K - Current report:
SEC Accession No. 0001564590-20-022847
Filing Date
2020-05-07
Accepted
2020-05-07 16:09:09
Documents
13
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20200507.htm   iXBRL 8-K 45841
2 EX-99.1 fgen-ex991_6.htm EX-99.1 229901
  Complete submission text file 0001564590-20-022847.txt   415692

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fgen-20200507.xsd EX-101.SCH 5776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20200507_lab.xml EX-101.LAB 18732
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20200507_pre.xml EX-101.PRE 11173
7 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20200507_htm.xml XML 3406
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 20856393
SIC: 2834 Pharmaceutical Preparations